These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
524 related items for PubMed ID: 19404933
1. Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis. van Eijk IC, de Vries MK, Levels JH, Peters MJ, Huizer EE, Dijkmans BA, van der Horst-Bruinsma IE, Hazenberg BP, van de Stadt RJ, Wolbink GJ, Nurmohamed MT. Arthritis Rheum; 2009 May; 60(5):1324-30. PubMed ID: 19404933 [Abstract] [Full Text] [Related]
7. Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis. Kiortsis DN, Mavridis AK, Filippatos TD, Vasakos S, Nikas SN, Drosos AA. J Rheumatol; 2006 May; 33(5):921-3. PubMed ID: 16541480 [Abstract] [Full Text] [Related]
8. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis]. Yang CH, Huang F, Deng XH, Zhang JL, Zhang LY, Guo JH, Liang DF, Wang LS, Zhang YM. Zhonghua Yi Xue Za Zhi; 2006 Sep 19; 86(35):2451-4. PubMed ID: 17156669 [Abstract] [Full Text] [Related]
9. [Clinical study of etanercept for treating ankylosing spondylitis]. Liang LQ, Zhan ZP, Ye YJ, Fu D, Xu HS, Yang XY. Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug 19; 28(8):1349-51. PubMed ID: 18753057 [Abstract] [Full Text] [Related]
15. Association of lipid and inflammatory markers with C-reactive protein in cardiovascular risk assessment for primary prevention. Jovicić S, Ignjatović S, Dajak M, Kangrga R, Majkić-Singh N. Clin Lab; 2009 Aug 19; 55(11-12):411-9. PubMed ID: 20225663 [Abstract] [Full Text] [Related]
17. The function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients. Cho KH, Park SH, Park JE, Kim YO, Choi I, Kim JJ, Kim JR. Clin Biochem; 2008 Jan 19; 41(1-2):56-64. PubMed ID: 17996200 [Abstract] [Full Text] [Related]